Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.75
+0.02 (0.17%)
Jun 23, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2017 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '17 2017 - 2018
Respiratory System Medications
1.30B
Log In
Log In
Log In
Log In
Upgrade
Blood Medications
112.37M
Log In
Log In
Log In
Log In
Upgrade
Gynecological Medications
77.38M
Log In
Log In
Log In
Log In
Upgrade
Gynecological Medications Growth
79.81%
Log In
Log In
Log In
Log In
Upgrade
Tonic Medicine
46.33M
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular and Cerebrovascular Drugs
41.33M
Log In
Log In
Log In
Log In
Upgrade
Orthopedic Medication
35.44M
Log In
Log In
Log In
Log In
Upgrade
Other Business
512.18K
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
53.42%
Log In
Log In
Log In
Log In
Upgrade
Other
21.55M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-59.40%
Log In
Log In
Log In
Log In
Upgrade
Open Throat Sword Spray (including Children's Type)
-
Log In
Log In
Log In
Log In
Upgrade
Open Throat Sword Spray (including Children's Type) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Strong Gastrodia Eucommia Capsules
-
Log In
Log In
Log In
Log In
Upgrade
Strong Gastrodia Eucommia Capsules Growth
-
Log In
Log In
Log In
Log In
Upgrade
Open Throat Spray Agent
-
Log In
Log In
Log In
Log In
Upgrade
Open Throat Spray Agent Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2017 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '17 2017 - 2018
China
1.63B
Log In
Log In
Log In
Log In
Upgrade
China Growth
36.10%
Log In
Log In
Log In
Log In
Upgrade